Phase Separation: Linking Cellular Compartmentalization to Disease

Trends in Cell Biology

Volumn 26, Issue 7, 2016, Pages 547-558

  Aguzzi, Adriano ^a   Altmeyer, Matthias ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Intrinsically disordered proteins; Liquid demixing; Low complexity domains; Neurodegeneration; Phase transition; Protein assembly and aggregation

Indexed keywords

PROTEIN AGGREGATE; PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL COMPARTMENTALIZATION; CELL ORGANELLE; DEGENERATIVE DISEASE; EUKARYOTIC CELL; FRONTOTEMPORAL DEMENTIA; GERMINAL VESICLE; HUMAN; HUNTINGTON CHOREA; LIQUID; NONHUMAN; OOCYTE; PARKINSON DISEASE; PHASE SEPARATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; VISCOSITY; ANIMAL; DISEASES; METABOLISM; PHASE TRANSITION;

ANIMALS; CELL COMPARTMENTATION; DISEASE; EUKARYOTIC CELLS; HUMANS; PHASE TRANSITION; PROTEINS;

EID: 84961869803     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2016.03.004     Document Type: Review

References (108)

1. Brangwynne C.P., et al. Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science 2009, 324:1729-1732.
2. Brangwynne C.P., et al. Active liquid-like behavior of nucleoli determines their size and shape in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4334-4339.
3. Han T.W., et al. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 2012, 149:768-779.
4. Kato M., et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 2012, 149:753-767.
5. Hyman A.A., et al. Cell biology. Beyond oil and water - phase transitions in cells. Science 2012, 337:1047-1049.
6. Weber S.C., et al. Getting RNA and protein in phase. Cell 2012, 149:1188-1191.
7. Hyman A.A., et al. Liquid-liquid phase separation in biology. Annu. Rev. Cell Dev. Biol. 2014, 30:39-58.
8. Zhu L., et al. Nuclear bodies: the emerging biophysics of nucleoplasmic phases. Curr. Opin. Cell Biol. 2015, 34:23-30.
9. Wright P.E., et al. Intrinsically disordered proteins in cellular signalling and regulation. Nat. Rev. Mol. Cell Biol. 2015, 16:18-29.
10. Malinovska L., et al. Protein disorder, prion propensities, and self-organizing macromolecular collectives. Biochim. Biophys. Acta 2013, 1834:918-931.
11. Li P., et al. Phase transitions in the assembly of multivalent signalling proteins. Nature 2012, 483:336-340.
12. Ramaswami M., et al. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 2013, 154:727-736.
13. King O.D., et al. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012, 1462:61-80.
14. Alberti S., et al. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 2009, 137:146-158.
15. Li Y.R., et al. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013, 201:361-372.
16. Feric M., et al. A nuclear F-actin scaffold stabilizes ribonucleoprotein droplets against gravity in large cells. Nat. Cell Biol. 2013, 15:1253-1259.
17. Feric M., et al. Soft viscoelastic properties of nuclear actin age oocytes due to gravitational creep. Sci. Rep. 2015, 5:16607.
18. Molliex A., et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 2015, 163:123-133.
19. Wippich F., et al. Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 2013, 152:791-805.
20. Hennig S., et al. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. J. Cell Biol. 2015, 210:529-539.
21. Courchaine E., et al. Paraspeckles: paragons of functional aggregation. J. Cell Biol. 2015, 210:527-528.
22. Lui J., et al. Granules harboring translationally active mRNAs provide a platform for P-body formation following stress. Cell Rep. 2014, 9:944-954.
23. Brangwynne C.P. Phase transitions and size scaling of membrane-less organelles. J. Cell Biol. 2013, 203:875-881.
24. Hyman A.A., et al. Beyond stereospecificity: liquids and mesoscale organization of cytoplasm. Dev. Cell 2011, 21:14-16.
25. Strzelecka M., et al. Dynamic control of Cajal body number during zebrafish embryogenesis. Nucleus 2010, 1:96-108.
26. Zwicker D., et al. Centrosomes are autocatalytic droplets of pericentriolar material organized by centrioles. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E2636-E2645.
27. Altmeyer M., et al. Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat. Commun. 2015, 6:8088.
28. Teloni F., et al. Readers of poly(ADP-ribose): designed to be fit for purpose. Nucleic Acids Res. 2016, 44:993-1006.
29. Patel A., et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 2015, 162:1066-1077.
30. Banjade S., et al. Phase transitions of multivalent proteins can promote clustering of membrane receptors. Elife 2014, Published online October 16, 2014. 10.7554/eLife.04123.
31. Hulsmann B.B., et al. The permeability of reconstituted nuclear pores provides direct evidence for the selective phase model. Cell 2012, 150:738-751.
32. Schmidt H.B., et al. Nup98 FG domains from diverse species spontaneously phase-separate into particles with nuclear pore-like permselectivity. Elife 2015, Published online January 6, 2015. 10.7554/eLife.04251.
33. Tompa P., et al. Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem. Sci. 2008, 33:2-8.
34. Weber S.C., et al. Inverse size scaling of the nucleolus by a concentration-dependent phase transition. Curr. Biol. 2015, 25:641-646.
35. Nott T.J., et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol. Cell 2015, 57:936-947.
36. Shevtsov S.P., et al. Nucleation of nuclear bodies by RNA. Nat. Cell Biol. 2011, 13:167-173.
37. Dundr M., et al. Biogenesis of nuclear bodies. Cold Spring Harb. Perspect. Biol. 2010, 2:a000711.
38. Schwartz J.C., et al. RNA seeds higher-order assembly of FUS protein. Cell Rep. 2013, 5:918-925.
39. Schwartz J.C., et al. Biochemical properties and biological functions of FET proteins. Annu. Rev. Biochem. 2015, 84:355-379.
40. Sankar S., et al. Promiscuous partnerships in Ewing's sarcoma. Cancer Genet. 2011, 204:351-365.
41. Kovar H. Dr Jekyll and Mr Hyde: the two faces of the FUS/EWS/TAF15 protein family. Sarcoma 2011, 2011:837474.
42. Deng H., et al. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014, 10:337-348.
43. Couthouis J., et al. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20881-20890.
44. Lin Y., et al. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol. Cell 2015, 60:208-219.
45. Berry J., et al. RNA transcription modulates phase transition-driven nuclear body assembly. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E5237-E5245.
46. Grob A., et al. Construction of synthetic nucleoli in human cells reveals how a major functional nuclear domain is formed and propagated through cell division. Genes Dev. 2014, 28:220-230.
47. Falahati H., et al. Nucleation by rRNA dictates the precision of nucleolus assembly. Curr. Biol. 2016, 26:277-285.
48. Elbaum-Garfinkle S., et al. The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:7189-7194.
49. Brangwynne C.P., et al. Polymer physics of intracellular phase transitions. Nat. Phys. 2015, 11:899-904.
50. Wang X., et al. Nucleic acid-binding specificity of human FUS protein. Nucleic Acids Res. 2015, 43:7535-7543.
51. Jankowsky E., et al. Specificity and nonspecificity in RNA-protein interactions. Nat. Rev. Mol. Cell Biol. 2015, 16:533-544.
52. Hudson W.H., et al. The structure, function and evolution of proteins that bind DNA and RNA. Nat. Rev. Mol. Cell Biol. 2014, 15:749-760.
53. Kraus W.L. PARPs and ADP-ribosylation: 50 years and counting. Mol. Cell 2015, 58:902-910.
54. Hottiger M.O. Nuclear ADP-ribosylation and its role in chromatin plasticity, cell differentiation, and epigenetics. Annu. Rev. Biochem. 2015, 84:227-263.
55. Bock F.J., et al. RNA regulation by poly(ADP-ribose) polymerases. Mol. Cell 2015, 58:959-969.
56. Daniels C.M., et al. The promise of proteomics for the study of ADP-ribosylation. Mol. Cell 2015, 58:911-924.
57. Leung A.K. Poly(ADP-ribose): an organizer of cellular architecture. J. Cell Biol. 2014, 205:613-619.
58. Gonczy P. Towards a molecular architecture of centriole assembly. Nat. Rev. Mol. Cell Biol. 2012, 13:425-435.
59. Jiang H., et al. Phase transition of spindle-associated protein regulate spindle apparatus assembly. Cell 2015, 163:108-122.
60. Decker M., et al. Limiting amounts of centrosome material set centrosome size in C. elegans embryos. Curr. Biol. 2011, 21:1259-1267.
61. Zhang H., et al. RNA controls polyQ protein phase transitions. Mol. Cell 2015, 60:220-230.
62. Guo L., et al. It's raining liquids: RNA tunes viscoelasticity and dynamics of membraneless organelles. Mol. Cell 2015, 60:189-192.
63. Bah A., et al. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch. Nature 2015, 519:106-109.
64. Wang J.T., et al. Regulation of RNA granule dynamics by phosphorylation of serine-rich, intrinsically disordered proteins in C. elegans. Elife 2014, 3:e04591.
65. Kwon I., et al. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell 2013, 155:1049-1060.
66. Burke K.A., et al. Residue-by-residue view of in vitro FUS granules that bind the C-terminal domain of RNA polymerase II. Mol. Cell 2015, 60:231-241.
67. Babu M.M., et al. Intrinsically disordered proteins: regulation and disease. Curr. Opin. Struct. Biol. 2011, 21:432-440.
68. Thandapani P., et al. Defining the RGG/RG motif. Mol. Cell 2013, 50:613-623.
69. Gerstberger S., et al. A census of human RNA-binding proteins. Nat. Rev. Genet. 2014, 15:829-845.
70. Zhong S., et al. Role of SUMO-1-modified PML in nuclear body formation. Blood 2000, 95:2748-2752.
71. Drisaldi B., et al. SUMOylation is an inhibitory constraint that regulates the prion-like aggregation and activity of CPEB3. Cell Rep. 2015, 11:1694-1702.
72. Morimoto D., et al. The unexpected role of polyubiquitin chains in the formation of fibrillar aggregates. Nat. Commun. 2015, 6:6116.
73. Hipp M.S., et al. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 2014, 24:506-514.
74. Jain S., et al. ATPase-modulated stress granules contain a diverse proteome and substructure. Cell 2016, 164:487-498.
75. Doyle S.M., et al. Protein rescue from aggregates by powerful molecular chaperone machines. Nat. Rev. Mol. Cell Biol. 2013, 14:617-629.
76. Buchan J.R., et al. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 2013, 153:1461-1474.
77. Poepsel S., et al. Determinants of amyloid fibril degradation by the PDZ protease HTRA1. Nat. Chem. Biol. 2015, 11:862-869.
78. Kroschwald S., et al. Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules. Elife 2015, 4:e06807.
79. Yang M., et al. Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy. Autophagy 2015, 11:214-224.
80. Wallace E.W., et al. Reversible, specific, active aggregates of endogenous proteins assemble upon heat stress. Cell 2015, 162:1286-1298.
81. Berchowitz L.E., et al. Regulated formation of an amyloid-like translational repressor governs gametogenesis. Cell 2015, 163:406-418.
82. Xiang S., et al. The LC domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 2015, 163:829-839.
83. Walther D.M., et al. Widespread proteome remodeling and aggregation in aging C. elegans. Cell 2015, 161:919-932.
84. Brundin P., et al. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 2010, 11:301-307.
85. Shulman J.M., et al. Parkinson's disease: genetics and pathogenesis. Annu. Rev. Pathol. 2011, 6:193-222.
86. Robberecht W., et al. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013, 14:248-264.
87. Aguzzi A., et al. Prions: protein aggregation and infectious diseases. Physiol. Rev. 2009, 89:1105-1152.
88. Aguzzi A., et al. Mammalian prion biology: one century of evolving concepts. Cell 2004, 116:313-327.
89. Guerreiro R., et al. SnapShot: genetics of ALS and FTD. Cell 2015, 160:798.
90. Kim H.J., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013, 495:467-473.
91. Uversky V.N. Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders. Front. Aging Neurosci. 2015, 7:18.
92. Ling S.C., et al. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013, 79:416-438.
93. Toretsky J.A., et al. Assemblages: functional units formed by cellular phase separation. J. Cell Biol. 2014, 206:579-588.
94. Ciryam P., et al. Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep. 2013, 5:781-790.
95. Murakami T., et al. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron 2015, 88:678-690.
96. Elbaum-Garfinkle S., et al. Liquids, fibers, and gels: the many phases of neurodegeneration. Dev. Cell 2015, 35:531-532.
97. Svetoni F., et al. Oxidative stress affects FET proteins localization and alternative pre-mRNA processing in cellular models of ALS. Free Radic. Biol. Med. 2014, 75(Suppl. 1):S51.
98. Woerner A.C., et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science 2016, 351:173-176.
99. Kwon I., et al. Poly-dipeptides encoded by the C9ORF72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 2014, 345:1139-1145.
100. Rulten S.L., et al. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage. Nucleic Acids Res. 2014, 42:307-314.
101. Wang W.Y., et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 2013, 16:1383-1391.
102. Jucker M., et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501:45-51.
103. Aguzzi A., et al. Cell biology of prions and prionoids: a status report. Trends Cell Biol. 2016, 26:40-51.
104. Luk K.C., et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
105. Jaunmuktane Z., et al. Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 2015, 525:247-250.
106. Frontzek K., et al. Amyloid-beta pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. Swiss Med. Wkly 2016, 146:w14287.
107. Jackrel M.E., et al. Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 2015, 9:90-109.
108. Soragni A., et al. A designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas. Cancer Cell 2016, 29:90-103.